HOME >> BIOLOGY >> NEWS
Scripps research scientists identify new regulatory mechanism for critical protein signaling domain

The study is being published in Science Express, an advanced online edition of the journal Science, on April 5. It will appear in the print version of Science later this spring.

In findings the authors called "unexpected and striking," the study found that a new regulating messenger IP4, a small soluble molecule, augments the binding of three different PH domain proteins to one of the most commonly recognized membrane lipids, PIP3. The study also showed that inhibiting production of IP4 can result in reduced protein binding to membranes and reduced activation of key signaling molecules in developing T cells, leading to a block of T cell maturation and to severe immunodeficiency in animal models.

"This study changes how we think about the T cell receptor signaling process and a well established general signaling mechanism, protein recruitment to membranes through PH domains," said Karsten Sauer, a Scripps Research scientist who led the study. "For the first time, we have clearly established a new way through which the PH domain can be positively regulated in vivo-IP4 augments the binding of PIP3 to these domains. In fact, it resembles PIP3. Until our study, the widely accepted idea was that recruitment of PIP3 binding PH domains to the membrane was primarily regulated by the supply and turnover of PIP3. The second completely new finding is that PH domain proteins can form aggregates through their PH domains. PH domain aggregation may enhance the membrane binding process."

Sauer suggests models for how IP4 might augment the binding of PIP3. In one, IP4 binds to a PH domain, changing its structure to one with a high affinity for IP4 and PIP3, a process commonly known as the "induced fit" model. In the second model, the PH domain pre-exists as an aggregate; IP4 binding to one subunit forces changes in the other subunit(s) so that they bind PIP3 with greater ease. This process is commonly known as an allosteric or cooperative mechanis
'"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
5-Apr-2007


Page: 1 2 3

Related biology news :

1. Scripps research scientists show protein accelerates breast cancer progression in animal models
2. Study led by Scripps Research scientist reveals little-known cell networks vital to circadian rhythm
3. Scripps research team sheds light on long-sought cold sensation gene
4. Scripps research study shows humans and plants share common regulatory pathway
5. Scripps research team discovers a chemical pathway that causes mice to overeat and gain weight
6. Scripps research study reveals structural dynamics of single prion molecules
7. Scripps research scientists: Compounds show significant promise against potential bioweapon toxins
8. Scripps Research study reveals new function of protein kinase pathway in tumor suppression
9. Scripps Research study reveals new activation mechanism for pain sensing channel
10. NYU, Scripps finding offers new path for treatment of diabetes
11. Reduced body temperature extends lifespan in study from the Scripps Research Institute

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... August 06, 2020 , ... ... in the prestigious National STEM Scholar Program, a unique professional development program that ... project support for middle school science teachers nationwide. , Created in partnership between ...
(Date:7/31/2020)... , ... July 30, 2020 , ... ... digital therapeutics product portfolio with a near term focus on Type 2 diabetes ... pharma commercialization experience across multiple therapeutic areas and classes. As Chief Commercial Officer, ...
(Date:7/10/2020)... FALLS CHURCH, Va. (PRWEB) , ... July 08, ... ... , The Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, ... product may need a comparability study, but what is the most effective way ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors ... (MIT) has expanded the company’s exclusive license to include clinical applications for ... diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and ...
(Date:7/7/2020)... ... , ... R3 International is now offering stem cell therapy for Alzheimers dementia ... on the patient's condition, treatment may be offered IV, intrathecal or with a combination. ... Alzheimers dementia, and the incidence continues to increase as individuals live longer. There is ...
(Date:7/1/2020)... ... June 29, 2020 , ... The ... purchasing contracts to its membership, recently named BioFit Engineered Products an ... opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at discounted ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 ... or drug treatment. In an effort to better understand the cellular responses to ... largest imaging dataset portraying therapeutic compound effects from over 1,600 approved and referenced ...
Breaking Biology Technology:
Cached News: